SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Dr Lal Pathlabs

BSE: 539524 29 Jul 2025
Healthcare
₹ 2962.85
Dr. Lal Pathlabs Limited specializes in Healthcare Service Provider within the Healthcare sector.

Dr Lal Pathlabs - Share Price & Details

Market Cap
₹25,330
High /Low
3,654 / 2,294
Stock P/E
51.8
Book Value
₹260.0
Dividend Yield
0.79
ROCE
28.9
ROE
₹24.3
Face Value
10.0
PEG Ratio
4.22
EVEBITDA
₹31.2
Debt
157
CMP / FCF
54.0
Debt to equity
₹0.07
NP Ann
492
High price all time
4,246
Piotroski score
₹8.0
Graham Number
584.0
No. Eq. Shares
8.38
Net CF
₹-68.3
Net profit
492
Price to book value
11.6
Interest Coverage
₹29.1
Low price all time
696.0
Industry PE
51.6
Reserves
₹2,089
Free Cash Flow
₹516

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
Dr. Lal Pathlabs Limited6,024.001,484.005,772.0017.7825,33051.8
Eris Lifesciences Limited4,215.20304.704,047.702.232446069.8
PFIZER LTD.6,364.903,309.405,919.1072.3424196158.0

Peer Comparison Chart


About Dr Lal Pathlabs

Dr. Lal Pathlabs Limited, with Security Code 539524, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Dr. Lal PathLabs Limited (539524) vs yyy - Free Real-Time Stock Data

(24 Jul 2025)
Dr. Lal PathLabs Limited (539524) vs yyy ✌️【Market Focus】✌️ Join thousands of investors using expert insights to grow their capital.
Read more →

Bullish Pattern Emerging on Dr. Lal PathLabs Limited (539524) - Free Trading Psychology Coaching

(24 Jul 2025)
Bullish Pattern Emerging on Dr. Lal PathLabs Limited (539524) ✌️【Stock Observations】✌️ Discover stocks primed for major upward moves with...
Read more →

Dr. Lal PathLabs Limited (LALPATHLAB) Signs Major Deal - Free Stock Market Forecast Reports

(23 Jul 2025)
Dr. Lal PathLabs Limited (LALPATHLAB) Signs Major Deal ✌️【Market Discussions】✌️ Our analysts track global markets daily to uncover stocks...
Read more →

Buy Dr Lal Pathlabs; target of Rs 3100: Emkay

(23 Jul 2025)
Emkay is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 3100 in its research report dated July...
Read more →

Bullish Pattern Emerging on Dr. Lal PathLabs Limited (539524) - Superior trading gains

(23 Jul 2025)
Bullish Pattern Emerging on Dr. Lal PathLabs Limited (539524) ✌️【Trading Ideas】✌️ Stock group insights to identify profitable stocks and...
Read more →

Dr. Lal PathLabs adds Illumina’s NovaSeq X Series to expand genomics capabilities

(26 Jun 2025)
Dr. Lal PathLabs Limited announces the addition of Illumina's NovaSeq X Series to enhance genomic testing capabilities, promising faster and...
Read more →

Company Updates